EricWilliamHumkeMDPhD

Vice President, Clinical Development, Apoptosis

Dr. Humke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
IGM Biosciences, Inc.
325 E Middlefield Rd
Mountain View, CA 94043
Phone+1 650-352-6270

Dr. Eric Humke is an oncologist who now runs clinical trials for oncology patients. He received his undergraduate degree from Brown University, his M.D., Ph.D. degrees from University of Michigan Medical School (with Vishva Dixit), internal medicine residency at Barnes-Jewish Hospital in St. Louis, and his medical oncology fellowship from Stanford. Dr. Humke performed post-doctoral training with Matthew Scott and Rajat Rohatgi in Hedgehog signaling and was on the staff at Stanford before going on to Genentech as a medical director for 9 years. He is now the Vice President of Clinical Development, Apoptosis at IGM Biosciences.

Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2006 - 2011
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2006
University of Michigan Medical SchoolClass of 2004

PubMed

101 citations
Activation of caspases triggered by cytochrome c in vitro.
Guoha Pan, Eric W. Humke, Vishva M. Dixit
FEBS Letters. 1998-04-10
376 citations
Caspase-9 Can Be Activated without Proteolytic Processing
Henning R. Stennicke, Quinn Deveraux, Eric W. Humke, John C. Reed, Vishva M. Dixit
The Journal of Biological Chemistry. 1999-03-26
116 citations
The PYRIN domain: a member of the death domain-fold superfamily.
Wayne J. Fairbrother, Nathaniel C. Gordon, Eric W. Humke, Karen O'Rourke, Melissa A. Starovasnik
Protein Science. 2001-09-01